Emotional Reactivity and Regulation Relate to Surgical Treatment Decision Making Among Newly Diagnosed Women With Breast Cancer
Cancer Medicine · 2024
DOI: 10.1002/cam4.70357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Catherine Benedict und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Decision Making. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, National Institute of Health.
Abstract (Originalsprache)
Background
Despite bilateral mastectomy (BLM) for early‐stage breast cancer (BC) showing no survival benefit and increased risk compared to breast conserving surgery, some patients still choose this treatment. This study examined whether emotion reactivity and regulation influence treatment decision making among newly diagnosed women with breast cancer.
Methods
Cross‐sectional survey data were analyzed as part of a larger study. Measures included the Contralateral Prophylactic Mastectomy (CPM) survey, PROMIS Anxiety scale, and Emotion Regulation Questionnaire (ERQ) Cognitive Reappraisal and Emotional Suppression subscales. Primary analysis included a logistic regression model predicting treatment choice (BLM vs. non‐BLM).
Results
Participants ( N = 137) with unilateral BC (Stages 0–III) were divided between BLM ( n = 66) versus breast conserving surgery (i.e., non‐BLM, n = 71) treatment groups. Compared to the non‐BLM group, the BLM group was younger, more likely to be partnered, and had a higher household income. Women with high levels of BC‐specific worry were 3.6 times more likely to choose BLM compared to women with low levels of worry (OR = 3.09, 95% CI: 1.07–0.8.93). Those who used cognitive reappraisal were 10% less likely to choose BLM compared to women who did not use cognitive reappraisal (OR = 0.90, 95% CI: 0.82–0.99). There were no group differences in levels of generalized anxiety (OR = 0.93, 95% CI: 0.87–0.99) or emotional suppression (OR = 1.02, 95% CI: 0.90–1.16).
Conclusions
Findings suggest the choice of BLM may be due, in part, to negative emotional experiences after a BC diagnosis and lesser use of reappraisal to reframe cancer‐related fears. These may be important targets of intervention to support women making BC treatment decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.
- Stanford Cancer Institute, Stanford, California, USA.
- Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, California, USA.
- Department of Medicine and of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, USA.
- Department of Psychology, Stanford University, Stanford, California, USA.
ORCID-Profile: Catherine Benedict
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- National Institute of Health
- National Cancer Institute
Zitieren
APA
Benedict, C., Nouriani, B., Neri, E., Miller, K., Kurian, A. W., Gross, J. J., & Spiegel, D. (2024). Emotional Reactivity and Regulation Relate to Surgical Treatment Decision Making Among Newly Diagnosed Women With Breast Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.70357
Vancouver
Benedict C, Nouriani B, Neri E, Miller K, Kurian AW, Gross JJ, et al. Emotional Reactivity and Regulation Relate to Surgical Treatment Decision Making Among Newly Diagnosed Women With Breast Cancer. Cancer Medicine. 2024. doi:10.1002/cam4.70357
BibTeX
@article{Benedict2024,
author = {Benedict, Catherine and Nouriani, Bita and Neri, Eric and Miller, Kate and Kurian, Allison W and Gross, James J and Spiegel, David},
title = {Emotional Reactivity and Regulation Relate to Surgical Treatment Decision Making Among Newly Diagnosed Women With Breast Cancer},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.70357}
}
EUVIMED